Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy. - Wikidata - awgldk - TriplyDB

Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.

Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.

http://www.wikidata.org/entity/Q35337927

about

Studying Cellular Signal Transduction with OMIC Technologies Precision medicine for cancer with next-generation functional diagnostics The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics Mitochondrial apoptosis and BH3 mimetics Caspase-8 activation by TRAIL monotherapy predicts responses to IAPi and TRAIL combination treatment in breast cancer cell lines Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypes Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection Epistatic mutations in PUMA BH3 drive an alternate binding mode to potently and selectively inhibit anti-apoptotic Bfl-1 Big-data-based edge biomarkers: study on dynamical drug sensitivity and resistance in individuals.Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia.Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma.Short-term culture of tumour slices reveals the heterogeneous sensitivity of human head and neck squamous cell carcinoma to targeted therapies.Mechanisms of cyclic AMP/protein kinase A- and glucocorticoid-mediated apoptosis using S49 lymphoma cells as a model system Constitutive BAK activation as a determinant of drug sensitivity in malignant lymphohematopoietic cells.Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.How to unleash mitochondrial apoptotic blockades to kill cancers?Bcl-2 protein family expression pattern determines synergistic pro-apoptotic effects of BH3 mimetics with hemisynthetic cardiac glycoside UNBS1450 in acute myeloid leukemia.Complementary dynamic BH3 profiles predict co-operativity between the multi-kinase inhibitor TG02 and the BH3 mimetic ABT-199 in acute myeloid leukaemia cells Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response.Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts.Biphasic ROS production, p53 and BIK dictate the mode of cell death in response to DNA damage in colon cancer cells Mitochondria and the hallmarks of cancer.Logic Modeling in Quantitative Systems Pharmacology.PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer.Mitochondria-Judges and Executioners of Cell Death Sentences.Monitoring drug induced apoptosis and treatment sensitivity in non-small cell lung carcinoma using dielectrophoresis.High CIP2A levels correlate with an antiapoptotic phenotype that can be overcome by targeting BCL-XL in chronic myeloid leukemia.BH3 profiling and a toolkit of BH3-mimetic drugs predict anti-apoptotic dependence of cancer cells.Constitutive p53 heightens mitochondrial apoptotic priming and favors cell death induction by BH3 mimetic inhibitors of BCL-xL To Prime, or Not to Prime: That Is the Question.Dexamethasone treatment promotes Bcl-2 dependence in multiple myeloma resulting in sensitivity to venetoclax.Targeting cell death signalling in cancer: minimising 'Collateral damage'.Integrated Strategies to Gain a Systems-Level View of Dynamic Signaling Networks.Interleukin 21 - its potential role in the therapy of B-cell lymphomas.Great expectations in acute myeloid leukemia.Cell death response to anti-mitotic drug treatment in cell culture, mouse tumor model and the clinic Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia.Bruton's tyrosine kinase inhibition increases BCL-2 dependence and enhances sensitivity to venetoclax in chronic lymphocytic leukemia.Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax.

P2860

Q24289429-D68771B3-DAD7-4236-9B1B-55926AE81F8E Q26780232-AC87A420-431E-4FB6-9A51-AFFEFB24407D Q27010154-DA6F8466-7B26-42CA-8BA0-6924F87492C9 Q28069552-60A2C64E-C041-4A81-97B5-E4EC9E31F69B Q30398758-D1EAC479-89D3-4AD5-8370-06264AA23799 Q33608593-41C99A83-3D3A-4C82-9913-83AFBC3FFC6E Q33658144-E7FC5D4C-F74C-4C28-A5E2-0E1A9089706E Q33779035-256E7CEB-E0CE-4C5C-9811-58F67B8E758B Q35789759-DB53546D-4710-405B-A7FB-B4CA4D9138CE Q35861111-12ACD93F-C32A-4A19-B0E1-0DA376E15DB0 Q35923299-7DD82AD9-C32E-44F8-BBB8-F237D83B8B5F Q35991729-891849DC-A3F1-44FD-98C1-429A8F2D83A7 Q36179180-251BB8FE-3AF2-45CE-9570-4A76A3FE2CB2 Q36199633-59456D4F-9192-47D5-BC39-3B77F9A27C9F Q36862936-5E736E8E-E385-49A7-9E48-559578363C88 Q37526352-B6F36F57-0815-40FA-B484-C05FB52BF789 Q37587294-4F76A3C0-FEDA-4918-A5FC-44AFF9D44126 Q37683375-68FC71FB-79BA-4E95-BE22-10FCA0B70D73 Q37725409-B459A3FB-87DD-47EF-87EC-B746ADB36CB8 Q38605020-5D6F22D7-8DAB-42F0-9CC6-17F9EB206FFA Q38611166-BC7333A4-E181-4B87-8477-38CACDCC32F9 Q38630410-F86D1079-1E3D-4188-B1A3-7F556F99DD1E Q38647795-B5B14544-5B2A-4397-820E-F2B18361E218 Q38691620-9E8A5CB2-9F1F-44EC-A5FC-83F2247461C8 Q38735131-5D33C117-F9DF-4BED-9A23-24CEF078F29E Q38760561-DC7A589F-AC20-4192-ADAB-DE8570CDBE79 Q38766487-2E462DBB-8C32-4E2F-865F-3A021D4F74E7 Q38785390-32680DFE-9F8F-4F36-BB98-9954A1AB22EE Q38787919-95653452-D510-4AB2-8B03-55C0186FB5FE Q38796648-62B833CC-4D0B-42F7-AF91-74AED269EDF8 Q38798849-C9D92B5D-2E17-4ACA-95E3-A8B3885DB39A Q38808802-562191F0-FAE0-4F16-9193-CB9CC146EB57 Q38824157-0BA64BFE-9718-4E6D-853B-CA656D173DD2 Q38881491-A974E5DE-7255-4CFF-8F77-B08939AFC303 Q38894228-D555BF46-2B6C-43F5-B121-992540E11BCB Q38920692-E0AE4EA1-3EC1-43E7-BF93-001BBC28583B Q38935027-D4F4CEAC-1338-4C94-910D-454CF275AA11 Q38999126-F5F35397-5889-4FA7-BF41-819AF1256401 Q39006397-FD141047-EFF7-4B85-AC1B-7E7B413382B1 Q39093595-3093C1C1-EF3D-4836-9630-9B2203CF47D7

P2860

Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.

http://www.wikidata.org/entity/Q35337927

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.

@ast

Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.

@en

type

label

Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.

@ast

Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.

@en

prefLabel

Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.

@ast

Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.

@en

P1433

Q35337927-E238E105-37F8-48B0-8C95-C48173871A8F

P1476

Q35337927-25F547BA-930D-405A-8B04-5CEDF5856D84

P2093

Q35337927-11B696AC-AF6F-49E0-823D-C3E8CDEAD7FC

Q35337927-28005BC8-49F3-4FC1-8F7B-AA0150534802

Q35337927-2D85A164-98F4-4AFE-BE7B-2E3F7C0AE875

Q35337927-356B8727-6CB7-4356-AA88-33C439B038AF

Q35337927-394F29EB-A15C-42DB-A2DD-B687B98906E0

Q35337927-3FECE3BA-0237-4D52-B376-8209E3D4BE36

Q35337927-4DA9DA8E-4933-4F2C-A56D-EF84722CC85D

Q35337927-80D7F74E-325F-4515-8087-09EF2D5B8B92

Q35337927-8727FBAE-2608-4D4C-8162-8FF35E6BD7EB

Q35337927-AB3FE11D-32A5-47BF-BBF1-6F95EF86CC05

P2860

Q35337927-02D9D2F2-D3D3-4559-953F-BD47741EABAE

Q35337927-035D1128-2AD4-4943-8EF2-597A4B12CFD1

Q35337927-05584A72-31E1-48E2-B5CB-433D1BC2C9BC

Q35337927-1983705F-602F-41F7-A62B-1C7D4CAC5FB6

Q35337927-23C7EE32-9E51-47B1-809E-BC3270520E68

Q35337927-2904C557-DEA1-4D46-9BBE-4507E79B09B8

Q35337927-338ABE1A-C534-4BB2-98C3-7B562B5339A0

Q35337927-36E685D5-4778-44A1-9CDA-1A3AA6AB8367

Q35337927-3F1A1B87-6087-440C-BFC4-068B5F07AF93

Q35337927-491E90D9-014A-4EBE-A9AD-1F6DDE1AB273

P304

Q35337927-136E03F5-9A28-4D61-8B20-7FACAF5BF6D1

P31

Q35337927-561585EC-287F-42C1-985C-D811E0D294F7

P356

Q35337927-657B0FE5-A68E-486B-8987-E3A2402DEA3F

P407

Q35337927-C58BD66E-5AB9-4149-992C-8B1B7147DEF5

P433

Q35337927-BF7C54D4-A007-4195-91CC-BC7597F8E8AC

P478

Q35337927-5A210DF3-1F3D-4FB8-990D-89BC10E253D7

P50

Q35337927-279D2B2C-BA5D-4B93-A0E9-3350F36D29F1

Q35337927-297DF80E-516F-438F-94E1-75C267160471

Q35337927-5156B019-9C4C-4147-8B88-6B9CE10FB3AE

Q35337927-800717AD-9219-478F-BEEA-5096E787E82E

Q35337927-D8C8A71B-C2DA-4E9F-A477-FE8A0623C021

P577

Q35337927-2F803AA0-BB1C-4CC7-A9C0-37384E048C1B

P5875

Q35337927-D3B9DB26-80A3-4D2F-8622-2994C805CCB3

P698

Q35337927-213E60A3-71E0-483F-B8AA-F373CD8BB39B

P921

Q35337927-6FB767AC-A2B8-4743-A1A8-361A184943C3

P932

Q35337927-6AEC231C-EA2D-48C7-948F-291A7399F467

P356

J.CELL.2015.01.042

P1433

P1476

Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.

@en

P2093

Anthony Letai

http://www.w3.org/2001/XMLSchema#string

Dalia Ercan

http://www.w3.org/2001/XMLSchema#string

Huiying Piao

http://www.w3.org/2001/XMLSchema#string

Karen Cichowski

http://www.w3.org/2001/XMLSchema#string

Neil S Horowitz

http://www.w3.org/2001/XMLSchema#string

Ophélia Maertens

http://www.w3.org/2001/XMLSchema#string

Pasi A Jänne

http://www.w3.org/2001/XMLSchema#string

Philip C Amrein

http://www.w3.org/2001/XMLSchema#string

Ross S Berkowitz

http://www.w3.org/2001/XMLSchema#string

Ursula Matulonis

http://www.w3.org/2001/XMLSchema#string

P2860

Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members

BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Novel mutant-selective EGFR kinase inhibitors against EGFR T790M

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers.

Reactivation of ERK signaling causes resistance to EGFR kinase inhibitors.

Elucidating distinct roles for NF1 in melanomagenesis

Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

P304

977-989

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELL.2015.01.042

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

160

http://www.w3.org/2001/XMLSchema#string

P50

Kristopher A Sarosiek

Joseph D DeAngelo

P577

2015-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272834295

http://www.w3.org/2001/XMLSchema#string

P698

25723171

http://www.w3.org/2001/XMLSchema#string

P921

P932

4391197

http://www.w3.org/2001/XMLSchema#string